Name | 2-[4-[4-[5-[[6-(trifluoromethyl)pyridin-3-yl]amino]pyridin-2-yl]phenyl]cyclohexyl]acetic acid |
---|---|
Synonyms |
Pradigastat [INN]
{trans-4-[4-(5-{[6-(Trifluoromethyl)-3-pyridinyl]amino}-2-pyridinyl)phenyl]cyclohexyl}acetic acid Cyclohexaneacetic acid, 4-[4-[5-[[6-(trifluoromethyl)-3-pyridinyl]amino]-2-pyridinyl]phenyl]-, trans- LCQ 908 Pradigastat LCQ 908NXA UNII-2U23G6VNUZ LCQ908-NXA LCQ-908 |
Description | Pradigastat (LCQ-908) is a diacylglycerol acyltransferase 1 (DGAT1) inhibitor. |
---|---|
Related Catalog | |
In Vivo | Pradigastat (LCQ-908) is a potent inhibitor of DGAT1, and has been used for the phase II clinical trials to treat diabetes and obesity[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 611.0±55.0 °C at 760 mmHg |
Molecular Formula | C25H24F3N3O2 |
Molecular Weight | 455.472 |
Flash Point | 323.3±31.5 °C |
Exact Mass | 455.182068 |
PSA | 75.11000 |
LogP | 6.10 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.582 |
Storage condition | 2-8℃ |